Investment
Features
FeesSafety
Academy
More
Pluang+
|
Home/Explore/US Market Price/Stocks/VTRS
icon
icon
Us company
Asset icon - trade crypto, stocks, and gold on Pluang

Viatris Inc (VTRS) Stock Price Today

TechnicalsFundamentalsFinancialsNewsCorp ActionAboutCompare
24H
1W
1M
3M
YTD
1Y
5Y

Aura AI Summary

Viatris (VTRS) trades at $17.46, down 1.47% today, with a bullish technical signal from moving averages and strong cash flow of $611.9M in 2025. Recent Q2 2026 earnings beat expectations with EPS of $0.69, and the company announced a $0.12 dividend for September 2026. Revenue has stabilized around $14.3B, though net income remains negative at -$3.51B for 2025. Analyst consensus is a $21.40 price target with a mixed buy/hold rating split.
The outlook is cautiously optimistic, supported by operational cash generation and debt reduction, but high P/E of 236.2 and negative margins pose valuation risks. Key opportunities include pipeline progress and dividend initiation, while headwinds involve competitive pressures and profitability challenges.
Read full analysis

Key Stats

  • Market Cap
    $20.22B
  • Volume
    7,511,219
  • Sector
    Health
  • 52W High
    $18.27
  • 52W Low
    $9.74
  • Typical Hold Time
    56 Days
  • Enterprise Value
    $32.34B
  • Div Yield
    2.73%
  • Trading Activity
    -
$17.6
52W Low: $9.74
10 Oct 2025
52W High: $18.27
28 Sep 2026

Track Viatris Inc (VTRS) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Viatris Inc has traded between a low of $9.74 and a high of $18.27, highlighting its annual price range. Buy and sell Viatris Inc shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.

About Viatris Inc

Formed by the combination of Mylan and Pfizer's Upjohn business in 2020, Viatris is one of the world's largest generic drug manufacturers, with a substantial off-patent branded drug portfolio. Its portfolio consists of more than 1,400 molecules with penetration across most of the developed world and in select emerging markets. The company's branded drug portfolio consists of off-patent blockbuster drugs that continue to generate strong sales, including Lipitor, Norvasc, Lyrica, Viagra, and EpiPen. While global competition has facilitated the commodification of small-molecule generic drugs, the company has demonstrated an edge over peers in its ability to manufacture complex generics (for example, generic Advair and Copaxone).

Most Recent News

Content is generated by Aura AI

Rocket Lab secures largest-ever commercial Electron rocket deal, boosting launch backlog past 100.

Rocket Lab has signed the biggest commercial deal in its history for its Electron rocket launches. This milestone deal significantly increases the company's launch backlog, which now exceeds 100 missions. The expanded backlog highlights strong demand...

Market News
1 hour ago
Daniel Miller
Neutral
Rocket Lab secures largest-ever commercial Electron rocket deal, boosting launch backlog past 100.

Covered-call ETFs JEPI, GPIX, and JEPQ pay varying dividends on $100K; JEPQ leads in income but with higher risk.

Three covered-call ETFs—JEPI, GPIX, and JEPQ—went ex-dividend on October 1, 2026, showing different income payouts on a $100,000 investment. JEPI, known for its defensive portfolio, paid $608.56 but cut its dividend from September. GPIX held steady a...

Market News
4 hours ago
24/7 Wall Street
Neutral
Covered-call ETFs JEPI, GPIX, and JEPQ pay varying dividends on $100K; JEPQ leads in income but with higher risk.

SpaceX's AI revenue expected to surpass other segments by September, Q3 report will confirm.

Elon Musk predicted in August 2026 that SpaceX's AI revenue would exceed all other business segments by September. While AI revenue grew significantly in Q2, it had not yet overtaken Connectivity and Space revenues. The Q3 earnings report, due in lat...

Market News
4 hours ago
24/7 Wall Street
Neutral
SpaceX's AI revenue expected to surpass other segments by September, Q3 report will confirm.
Catch up fast with Aura AI
Get an AI-generated news summary for this asset in seconds.

People also bought

Frequently Asked Questions

US stocks trading hours: Monday - Friday (Except for US public holidays) Time: 21.30 - 04.00 WIB 20.30 - 03.00 WIB (Daylight Savings Time*) *The next Daylight Savings is scheduled to begin on March 13, 2022 and ends on November 6, 2022. You can place limit orders outside of the trading hours, but it can only be executed during trading hours. For illustration, a stock is currently trading at $10 per share, but you only want to pay $7 per share at most. Let’s say you set your limit price to $7 at 18.00. Your order will be executed when the market is open at 21.30 if the stock drops from $10 to $7 or lower. Similarly, if the stock price doesn’t drop to $7, your order won’t be executed.
Yes, you are eligible to receive dividend payment if and when the company pays them on one condition: minimum net dividend paid is at least $0.01. Net dividend is gross dividend subtracted by 15% withholding tax.
Yes, it is. US Stocks risk is managed by PT PG Berjangka which is licensed by Badan Pengawas Perdagangan Berjangka Komoditi (BAPPEBTI), and your investment is guaranteed by Jakarta Futures Exchange (JFX) and Indonesian Clearing House (KBI).
Pluang charges a fixed transaction fee of 0.30% for regular users and 0.20% for Pluang Plus members, including VAT to cover the exchange fees and operational costs.
US Stocks, ETFs, and Options are facilitated by PT PG Berjangka in its capacity as a Licensed Derivatives Broker supervised by the Financial Services Authority of Indonesia (OJK) for financial derivative products with underlying securities. All transactions are recorded on the Jakarta Futures Exchange (JFX) and the Indonesian Futures Clearing House (KBI). In addition, PT PG Berjangka is also a Licensed Futures Broker supervised by the Commodity Futures Trading Regulatory Agency (Bappebti). Read our product’s Terms and Conditions

All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.

Key Stats

  • Market Cap
    $20.22B
  • Volume
    7,511,219
  • Sector
    Health
  • 52W High
    $18.27
  • 52W Low
    $9.74
  • Typical Hold Time
    56 Days
  • Enterprise Value
    $32.34B
  • Div Yield
    2.73%
  • Trading Activity
    -
$17.6
52W Low: $9.74
10 Oct 2025
52W High: $18.27
28 Sep 2026

Track Viatris Inc (VTRS) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Viatris Inc has traded between a low of $9.74 and a high of $18.27, highlighting its annual price range. Buy and sell Viatris Inc shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.

Let’s invest in this asset by signing up or download!